- Phase I-2018: Done
WP1. Investigate multifunctional hybrid magnetic nanoparticles structure-property relationship
- Phase II-2019: Done
WP2. Develop hybrid magnetic nanoparticle 99mTc radiolabeling procedure
WP3. In vitro evaluation of hybrid magnetic nanoparticles on normal and different pathological (tumoral and nontumoral) cells
WP4. In vivo biodistribution with quantitative evaluation of the new radiotracer on small animals (normal and tumoral tissues)
- Phase III-2020: Done
WP5. Multimodal imaging evaluation of the obtained nanotracer using SPECT and MRI and comparison studies with fluorescent/PET on small animals